Australian scientists develop potential cure for peanut allergies

Image
IANS Canberra
Last Updated : Jan 28 2015 | 11:55 PM IST

Australian scientists believe they have developed a possible cure for people with severe peanut allergies.

Researchers from the Murdoch Children's Research Institute in Melbourne have invented a particular strain of probiotics, testing the friendly bacteria on 60 children who are allergic to peanuts.

The study revealed that 80 percent of the children tested tolerated the probiotic, in addition with either peanut protein or a placebo, without any allergic reactions whatsoever.

Meanwhile, of the 28 children who were tested with peanut protein, three were able to eat peanuts following the study.

Despite the positive initial steps, researchers stressed that some children did still have allergic reactions following the process.

"It seems we have been able to modify the allergic response to peanuts such that the immune system produces protective responses rather than a harmful response to the peanut protein," Xinhua news agency quoted lead researcher and associate Professor Mimi Tang as telling the ABC Wednesday.

Peanut allergies have increased by 350 percent in westernised countries over the last 20 years, with a recent Australian study finding that 10 percent of all 12-month-old babies were allergic to peanuts, as well as 3 percent of all infants.

Although further work is required to confirm whether the children tested acquired a long-term resistance to peanut allergies, Tang believes it's an encouraging first step.

"This is a promising therapy in the context of the increase in peanut allergy incidence," she said.

Peanut allergies are the most common cause of death due to food allergies.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 28 2015 | 11:52 PM IST

Next Story